Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $2.86 million. The enterprise value is -$3.03 million.
Important Dates
The last earnings date was Friday, March 6, 2026, before market open.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 1.43 million shares outstanding. The number of shares has increased by 244.55% in one year.
| Current Share Class | 1.43M |
| Shares Outstanding | 1.43M |
| Shares Change (YoY) | +244.55% |
| Shares Change (QoQ) | +23.36% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 2.75% |
| Float | 1.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.42
| Current Ratio | 4.42 |
| Quick Ratio | 4.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -170.73% and return on invested capital (ROIC) is -104.33%.
| Return on Equity (ROE) | -170.73% |
| Return on Assets (ROA) | -83.20% |
| Return on Invested Capital (ROIC) | -104.33% |
| Return on Capital Employed (ROCE) | -147.82% |
| Weighted Average Cost of Capital (WACC) | 11.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.60M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.96% in the last 52 weeks. The beta is 1.32, so ADIL's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -88.96% |
| 50-Day Moving Average | 3.56 |
| 200-Day Moving Average | 7.62 |
| Relative Strength Index (RSI) | 35.94 |
| Average Volume (20 Days) | 160,281 |
Short Selling Information
The latest short interest is 27,868, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 27,868 |
| Short Previous Month | 33,643 |
| Short % of Shares Out | 1.95% |
| Short % of Float | 2.13% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.80M |
| Pretax Income | -7.98M |
| Net Income | -7.98M |
| EBITDA | -7.80M |
| EBIT | -7.80M |
| Earnings Per Share (EPS) | -$11.93 |
Full Income Statement Balance Sheet
The company has $5.88 million in cash and n/a in debt, with a net cash position of $5.88 million or $4.12 per share.
| Cash & Cash Equivalents | 5.88M |
| Total Debt | n/a |
| Net Cash | 5.88M |
| Net Cash Per Share | $4.12 |
| Equity (Book Value) | 5.28M |
| Book Value Per Share | 4.75 |
| Working Capital | 4.78M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -6.49M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 565 |
| Net Borrowing | n/a |
| Free Cash Flow | -6.49M |
| FCF Per Share | -$4.55 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -244.55% |
| Shareholder Yield | -244.55% |
| Earnings Yield | -279.32% |
| FCF Yield | -227.34% |
Analyst Forecast
The average price target for ADIL is $37.50, which is 1,775.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.50 |
| Price Target Difference | 1,775.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 6, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Feb 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |